Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

Market Cap	7.99B +25.8%
Revenue (ttm)	2.89B +32.5%
Net Income	130.82M -31.0%
EPS	0.52 -36.6%
Shares Out	249.40M
PE Ratio	61.60
Forward PE	22.63
Dividend	0.25 (0.78%)
Ex-Dividend Date	Jul 10, 2025

Volume	4,382,865
Average Volume	5,849,236
Open	30.97
Previous Close	31.13
Day's Range	30.97 - 32.18
52-Week Range	25.60 - 43.60
Beta	0.03
RSI	36.12
Earnings Date	Mar 18, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-pantothenate calcium, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 2,191
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688639

Financial Performance

In 2025, SHA:688639's revenue was 2.89 billion, an increase of 32.50% compared to the previous year's 2.18 billion. Earnings were 130.82 million, a decrease of -30.97%.